Published in Cancer Epidemiol Biomarkers Prev on December 01, 2016
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62
Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet (2004) 6.37
Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol (2014) 4.00
Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med (2016) 3.05
Uses and abuses of meta-analysis. Clin Med (2002) 1.60
Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer (2015) 1.32
Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk. J Natl Cancer Inst (2012) 1.19
Obesity and cancer: An update of the global impact. Cancer Epidemiol (2016) 1.02
Commentary: like it and lump it? Meta-analysis using individual participant data. Int J Epidemiol (2010) 0.98
Body mass index and cancer incidence: the FINRISK study. Eur J Epidemiol (2014) 0.98
Obesity and risk of bladder cancer: a meta-analysis of cohort studies. Asian Pac J Cancer Prev (2013) 0.94
The association between BMI and cervical cancer risk: a meta-analysis. Eur J Cancer Prev (2016) 0.86
Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies. PLoS One (2015) 0.85
Anthropometric measures and bladder cancer risk: a prospective study in the EPIC cohort. Int J Cancer (2014) 0.84
Estimating the Influence of Obesity on Cancer Risk: Stratification by Smoking Is Critical. J Clin Oncol (2016) 0.82